Marianne Skeie

  • Head Engineer
  • +47 23 07 40 74

Office: A3.3022

UiO home page


Publications 2020

Skeie M, Nikolaysen F, Chitano Y, Stang E (2020)
Hsp90 inhibition and co-incubation with pertuzumab induce internalization and degradation of trastuzumab: Implications for use of T-DM1
J Cell Mol Med, 24 (17), 10258-10262
DOI 10.1111/jcmm.15643, PubMed 32672902

Publications 2019

Dietrich M, Malik MS, Skeie M, Bertelsen V, Stang E (2019)
Protein kinase C regulates ErbB3 turnover
Exp Cell Res, 382 (2), 111473
DOI 10.1016/j.yexcr.2019.06.018, PubMed 31233741

Publications 2018

Dietrich M, Malik MS, Nikolaysen F, Skeie M, Stang E (2018)
Protein kinase C mediated internalization of ErbB2 is independent of clathrin, ubiquitination and Hsp90 dissociation
Exp Cell Res, 371 (1), 139-150
DOI 10.1016/j.yexcr.2018.08.004, PubMed 30098331

Publications 2017

Fosdahl AM, Dietrich M, Schink KO, Malik MS, Skeie M, Bertelsen V, Stang E (2017)
ErbB3 interacts with Hrs and is sorted to lysosomes for degradation
Biochim Biophys Acta Mol Cell Res, 1864 (12), 2241-2252
DOI 10.1016/j.bbamcr.2017.08.011, PubMed 28867611

Publications 2012

Hughes JB, Rødland MS, Hasmann M, Madshus IH, Stang E (2012)
Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab
Pharmaceuticals (Basel), 5 (7), 674-89
DOI 10.3390/ph5070674, PubMed 24281706

Vuong TT, Berger C, Bertelsen V, Rødland MS, Stang E, Madshus IH (2012)
Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomes
Exp Cell Res, 319 (3), 32-45
DOI 10.1016/j.yexcr.2012.10.010, PubMed 23127513

Publications 2011

Bertelsen V, Sak MM, Breen K, Rødland MS, Johannessen LE, Traub LM, Stang E, Madshus IH (2011)
A chimeric pre-ubiquitinated EGF receptor is constitutively endocytosed in a clathrin-dependent, but kinase-independent manner
Traffic, 12 (4), 507-20
DOI 10.1111/j.1600-0854.2011.01162.x, PubMed 21226813

Publications 2009

Hughes JB, Berger C, Rødland MS, Hasmann M, Stang E, Madshus IH (2009)
Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization
Mol Cancer Ther, 8 (7), 1885-92
DOI 10.1158/1535-7163.MCT-09-0291, PubMed 19584234

Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH (2009)
Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2
Mol Cancer Res, 7 (2), 275-84
DOI 10.1158/1541-7786.MCR-07-2183, PubMed 19208749

Publications 2008

Grøvdal LM, Johannessen LE, Rødland MS, Madshus IH, Stang E (2008)
Dysregulation of Ack1 inhibits down-regulation of the EGF receptor
Exp Cell Res, 314 (6), 1292-300
DOI 10.1016/j.yexcr.2007.12.017, PubMed 18262180

Kazazic M, Bertelsen V, Pedersen KW, Vuong TT, Grandal MV, Rødland MS, Traub LM, Stang E, Madshus IH (2008)
Epsin 1 is involved in recruitment of ubiquitinated EGF receptors into clathrin-coated pits
Traffic, 10 (2), 235-45
DOI 10.1111/j.1600-0854.2008.00858.x, PubMed 19054389

Publications 2004

Lindbäck T, Fagerlund A, Rødland MS, Granum PE (2004)
Characterization of the Bacillus cereus Nhe enterotoxin
Microbiology (Reading), 150 (Pt 12), 3959-67
DOI 10.1099/mic.0.27359-0, PubMed 15583149

Page visits: 222